BYAH

NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd. (“Park Ha” or the “Company”) (NASDAQ: BYAH).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, Aug. 18, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH).

Retail investors funneled into WhatsApp groups were told BYAH would climb 200% to 300% on a rumored L'Oréal partnership; instead the stock fell 93% in one session, and the lawsuit contends the Company never disclosed the promotional scheme driving its shares Retail investors funneled into WhatsApp groups were told BYAH would climb 200% to 300% on a rumored L'Oréal partnership; instead the stock fell 93% in one session, and the lawsuit contends the Company never disclosed the promotional scheme driving its shares

NEW YORK, Aug. 18, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) between December 27, 2024 and July 8, 2025, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.

New York, New York--(Newsfile Corp. - August 17, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) (NASDAQ: BYAH) between December 27, 2024 and July 8, 2025, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.

Park Ha Biological Technology Co., Ltd.'s IPO prospectus warned generically that low-float stocks "may" experience extreme run-ups, but the lawsuit contends it never disclosed that BYAH shares were already the target of a coordinated pump-and-dump promotion before the stock collapsed 93% in one session. Park Ha Biological Technology Co., Ltd.'s IPO prospectus warned generically that low-float stocks "may" experience extreme run-ups, but the lawsuit contends it never disclosed that BYAH shares were already the target of a coordinated pump-and-dump promotion before the stock collapsed 93% in one session.

NEW YORK, Aug. 16, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) between December 27, 2024 and July 8, 2025, inclusive (the “Class Period”), of the important September 28, 2026 lead plaintiff deadline.

NEW YORK, Aug. 14, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH).

New York, New York--(Newsfile Corp. - August 13, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) (NASDAQ: BYAH) between December 27, 2024 and July 8, 2025, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.

NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) between December 27, 2024 and July 8, 2025, inclusive (the “Class Period”), of the important September 28, 2026 lead plaintiff deadline.